LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Medicine recalls, shortages and safety updates in the UK — January 2026

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

expand all dayscollapse all days

22 Jan 2026Thursday 22 January 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Isotretinoin
The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

21 Jan 2026Wednesday 21 January 2026

open day ◀ ▶ 1 event · 1 important
Medicines recall Fingolimod Glenmark 0.5 mg Hard Capsules
Class 3 recall · DMRC-38142990 · PL: 25258/0323 · Glenmark Pharmaceuticals Europe Limited · fingolimod hydrochloride
Batches: 1501919 (29/02/2027)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

20 Jan 2026Tuesday 20 January 2026

open day ◀ ▶ 1 event · 1 important
Medicines recall Paliperidone Mercury Pharma 50 mg prolonged-release suspension for injection in pre-filled syringe
Class 2 recall · DMRC-37923982 · PLGB: 12762/0671 · Mercury Pharmaceuticals Ltd · paliperidone palmitate
Batches: 4400353 (30/06/2026), 4301747 (30/09/2026), 4400797 (30/09/2026), 4401269 (30/09/2026), 4401271 (30/09/2026), 4301534 (30/06/2026), 4301945 (30/06/2026), 4301883 (30/09/2026), 4400979 (30/09/2026), 4400711 (31/10/2026), 4401437 (30/06/2027), 4500150R (31/12/2027), 4500154R (31/12/2027), 4500171R (31/12/2027), 4500176 (31/01/2028), 4500443R (31/03/2028), 4501272 (31/08/2028), 4301518 (30/06/2026), 4301550 (30/06/2026), 4301970 (30/06/2026), 4400390 (30/06/2026), 4400737 (30/06/2026), 4401361 (30/06/2027), 4500100 (31/12/2027), 4500280 (31/01/2028), 4500675 (31/05/2028), 4500750 (31/05/2028), 4500825 (31/05/2028), 4500894 (31/05/2028), 4501516 (30/09/2028), 4301538 (30/06/2026), 4301930 (30/06/2026), 4301817 (30/09/2026), 4401337 (30/09/2026), 4401338 (30/09/2026), 4401277 (30/09/2026), 4400150 (31/10/2026), 4400169 (31/12/2026), 4500200 (31/01/2028), 4500197R (31/01/2028), 4500596 (30/04/2028), 4500689 (30/04/2028), 4500709R (31/05/2028), 4501340 (31/07/2028), 4501371 (31/08/2028)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

8 Jan 2026Thursday 8 January 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z
The MHRA has reviewed the warnings regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs. The findings (detailed in the Public Assessment…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

2 Jan 2026Friday 2 January 2026

open day ◀ ▶ 1 event
MHRA approval zapomeran (Kostaive) mRNA COVID-19 vaccine
As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review.
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency
← newer days

In total 8 events this month.